Title | Lorazepam - Med Map |
---|---|
Author | Joseline Landa |
Course | Medical Surgical |
Institution | American Career College |
Pages | 1 |
File Size | 116.7 KB |
File Type | |
Total Downloads | 98 |
Total Views | 137 |
Medication ATI worksheet for Lorazepam...
Joseline landa lorazepam - Ativan, Lorazepam Intensol, Nu-Loraz (CAN) Benzodiazepine, Anxiolytic
lorazepam hyperpolarizes neuronal cells, thereby interfering with their ability to generate seizures.
Expected therapeutic use is to help patient reduce anxiety
CNS: Amnesia, anxiety, ataxia, coma, confusion, delusions, depression, dizziness, drowsiness, euphoria, extrapyramidal symptoms, fatigue, headache, hypokinesia, irritability, malaise, nervousness, seizures, slurred speech, suicidal ideation, tremor, unsteadiness, vertigo CV: Chest pain, palpitations, tachycardia EENT: Blurred vision, diplopia, dry mouth, increased salivation, photophobia ENDO: Syndrome of inappropriate ADH GI: Abdominal pain, constipation, diarrhea, elevated liver enzymes, jaundice, nausea, thirst, vomiting
2 to 3 mg twice daily or three times daily, increased as needed. I.V. INJECTION: 0.044 mg/kg or 2 mg, whichever is less, given at 2 mg/min 2 hr before procedure. 0.05 mg/kg up to maximum dosage 2 hr before procedure. Maximum: 4 mg.
Acute angle-closure glaucoma; hypersensitivity to lorazepam, other benzodiazepines, or their components; For parenteral form: intraarterial delivery premature infants, severe respiratory insufficiency (except in patients requiring anxiety relief and/or diminished recall of events while being mechanically ventilated), sleep apnea syndrome
aminophylline, theophylline: Possibly reduced sedative effects of lorazepam clozapine: Increased risk of ataxia, delirium, excessive salivation, hypotension, marked sedation, and respiratory arrest CNS depressants: Additive CNS depression, potentially fatal respiratory depression fentanyl: Possibly decreased therapeutic effects of fentanyl probenecid, valproate: Possibly increased therapeutic and adverse effects of lorazepam other benzodiazepines, sedating antihistamines, opioids, tricyclic antidepressants: Increased risk of profound respiratory depression, sedation, and somnolence
Medication illustrates to be-not as effective due to its low dosage required to treat affected areas; there are a-lot of adverse reactions meaning more risks of lethal reactions
Monitor patient's respiratory status closely because drug may cause lifethreatening respiratory depression. Before starting lorazepam therapy in a patient with depression, make sure he already takes an antidepressant, because of the increased risk of suicide in patients with untreated depression.
Instruct patient to take lorazepam exactly as prescribed and not to stop without consulting prescriber because of the risk of withdrawal symptoms. Advise patient to avoid hazardous activities until drug's CNS effects are known. Instruct patient to report excessive drowsiness and nausea....